influenza
viru
ifv
major
respiratori
pathogen
global
import
caus
high
degre
morbid
mortal
especi
highrisk
popul
infant
elderli
immunocompromis
host
given
high
capac
chang
antigen
acquir
immun
often
effect
limit
ifv
infect
therefor
vaccin
must
constantli
redesign
achiev
effect
protect
improv
respiratori
system
innat
immun
mechan
propos
reduc
incid
sever
ifv
diseas
last
decad
sever
research
work
demonstr
microb
capac
modul
mucos
immun
system
immunobiot
potenti
altern
benefici
modul
outcom
ifv
infect
review
provid
updat
current
statu
modul
respiratori
immun
oral
nasal
administ
immunobiot
benefici
impact
ifv
clearanc
inflammatorymedi
lung
tissu
damag
particular
describ
research
group
investig
influenc
immunobiot
inflammationcoagul
interact
ifv
infect
studi
clearli
demonstr
hostil
inflamm
accompani
dysfunct
coagul
respiratori
ifv
diseas
investig
prove
immunobiot
strain
abl
reduc
viral
diseas
sever
capac
modul
immunecoagul
respons
respiratori
tract
keyword
immunobiot
influenza
viru
inflamm
coagul
respiratori
immun
introduct
influenza
viru
ifv
member
orthomyxovirida
famili
contain
negativesens
singlestrand
segment
rna
genom
protect
capsid
viral
ribonucleoprotein
viru
categor
subtyp
base
express
hemagglutinin
ha
neuraminidas
surfac
viral
envelop
influenza
highli
contagi
viral
infect
substanti
impact
global
health
ifv
major
respiratori
pathogen
caus
high
degre
morbid
mortal
especi
highrisk
popul
infant
elderli
immunocompromis
host
given
high
capac
ifv
chang
antigen
acquir
immun
often
effect
limit
infect
therefor
vaccin
must
constantli
redesign
achiev
protect
improv
respiratori
system
innat
immun
mechan
propos
reduc
incid
sever
ifv
diseas
last
decad
sever
research
work
demonstr
microb
capac
modul
mucos
immun
system
immunobiot
potenti
altern
benefici
modul
outcom
ifv
infect
review
provid
updat
current
statu
modul
respiratori
immun
oral
nasal
administ
immunobiot
benefici
impact
ifv
clearanc
inflammatorymedi
lung
tissu
damag
particular
describ
research
group
investig
influenc
immunobiot
inflammationcoagul
interact
ifv
infect
studi
clearli
demonstr
hostil
inflamm
accompani
dysfunct
coagul
respiratori
ifv
diseas
investig
prove
immunobiot
strain
abl
reduc
viral
diseas
sever
capac
modul
immunecoagul
respons
respiratori
tract
first
barrier
protect
host
ifv
infect
respiratori
epithelium
capac
recogn
viral
attack
ifv
success
overcom
respiratori
barrier
constitut
mucu
layer
ciliar
movement
mediat
attach
intern
respiratori
epitheli
cell
start
replic
viral
attack
sever
pathogenassoci
molecular
pattern
pamp
expos
recogn
patternrecognit
receptor
prr
express
respiratori
cell
figur
well
establish
import
prr
involv
recognit
ifv
tolllik
receptor
tlr
rna
recognit
protein
express
endosom
abl
recogn
viral
doublestrand
rna
dsrna
produc
viral
replic
endosom
cytoplasm
rigi
recogn
singlestrand
rna
ssrna
rigi
signal
mitochondri
antivir
signal
protein
pampsppr
interact
lead
activ
sever
signal
pathway
induc
activ
nuclear
factor
interferon
ifn
regulatori
factor
product
type
iii
ifn
inflammatori
cytokin
type
ifn
especi
produc
releas
earlier
stage
ifv
infect
key
develop
antivir
state
respiratori
tract
report
human
bronchial
epitheli
cell
releas
preform
respons
ifv
challeng
induc
protect
role
ifn
produc
infect
cell
abl
act
paracrin
autocrin
manner
activ
receptor
ifnar
increas
express
hundr
gene
counteract
viral
replic
function
genom
studi
identifi
sever
ifninduc
factor
import
role
control
ifv
replic
includ
ifninduc
transmembran
protein
protein
synthetas
oa
rnaasel
system
proinflammatori
cytokin
chemokin
produc
result
rigi
activ
ifv
infect
also
import
gener
respiratori
antivir
innat
immun
respons
infect
epitheli
cell
ifv
increas
express
rant
product
cytokin
complement
activ
inflammasom
induc
activ
promot
gener
activ
form
figur
ifv
shown
activ
mainli
inflammasom
essenti
protect
viru
sinc
sever
studi
demonstr
mice
lack
decreas
secret
increas
mortal
ifv
challeng
proinflammatori
cytokin
chemokin
respons
activ
resid
immun
cell
innat
lymphoid
cell
alveolar
macrophag
dendrit
cell
dc
well
recruit
neutrophil
macrophag
lymphocyt
respiratori
tract
figur
respiratori
cell
infect
ifv
express
ha
surfac
import
recognit
nk
cell
establish
ha
express
infect
cell
recogn
receptor
nk
cell
mediat
lysi
ifvinfect
cell
macrophag
activ
ifv
infect
produc
ifn
nitric
oxid
synthas
amplifi
inflammatori
respons
addit
macrophag
limit
viral
spread
elimin
apoptoticinfect
cell
phagocytemedi
opsonophagocytosi
ifv
product
proinflammatori
cytokin
gener
respiratori
innat
immun
respons
ifv
also
condit
adapt
immun
respons
includ
product
virusspecif
system
mucos
antibodi
well
induct
specif
cell
respons
exposur
ifv
activ
antibodi
respons
respiratori
tract
upper
airway
exposur
result
primarili
iga
respons
contact
ifv
deep
lung
induc
increas
product
pathogenspecif
igg
follow
exposur
ifv
airway
antigen
uptak
process
dc
activ
th
cell
gener
igaproduc
plasma
cell
popul
airway
lamina
propria
secretori
iga
noninflammatori
protect
function
sinc
antibodi
bind
viru
without
activ
complement
stimul
releas
inflammatori
mediat
innat
immun
cell
iga
prevent
ifv
adher
epitheli
surfac
induc
viral
agglutin
mask
adhes
epitop
deep
lung
ifv
reach
alveolar
space
differenti
expans
antibodysecret
plasma
cell
commit
product
igg
induct
neutral
respiratori
serum
igg
antibodi
key
event
defens
influenza
infect
sinc
igg
prevent
system
spread
influenza
infect
lung
also
activ
cellular
adapt
immun
respons
stimul
product
cell
effect
activ
cell
macrophag
clear
viru
infect
cell
lung
therefor
uncompl
influenza
adapt
immun
respons
ultim
result
clearanc
ifv
lung
activ
virusspecif
antibodi
cell
gut
microbiom
defin
collect
group
microorgan
associ
gene
within
intestin
tract
consid
key
player
modul
host
intestin
immun
respons
fact
impact
gut
commens
bacteria
innat
adapt
immun
respons
enter
pathogen
recogn
conclus
howev
effect
gut
microbiom
immun
respons
distal
mucos
site
impact
outcom
respiratori
infect
recent
expos
regard
studi
demonstr
import
role
intestin
microbiota
maintain
respiratori
antivir
immun
ifv
iwasaki
colleagu
observ
commens
bacteria
within
gut
especi
gramposit
bacteri
popul
import
role
support
appropri
immun
respons
ifv
infect
respiratori
tract
work
demonstr
oral
antibiot
treatment
impair
resist
mice
intranas
infect
ifv
note
elev
lung
viral
titer
compar
nonantibiotictr
anim
result
indic
gut
gramposit
bacteria
provid
protect
trigger
adequ
inflammatori
respons
inflammasom
activ
antibiotictr
mice
synthesi
impair
even
steadi
state
addit
deplet
gramposit
bacteri
popul
gut
result
alter
distribut
activ
respiratori
dc
steadi
state
well
diminish
dc
migrat
lung
drain
lymph
node
result
reduc
activ
cell
influenza
challeng
alter
respiratori
dc
activ
also
correl
impair
expans
influenzaspecif
b
cell
reduc
influenzaspecif
antibodi
use
germfre
antibiotictr
mice
challeng
ifv
abt
et
al
show
absenc
alter
intestin
microbiota
induc
exacerb
weight
loss
greater
drop
blood
oxygen
satur
increas
mortal
elev
lung
viral
titer
indic
weaker
abil
resist
influenza
even
germfre
antibiotictr
mice
infect
ifv
experienc
higher
epitheli
cell
necrosi
peribronchiolar
inflamm
sever
bronchiol
epitheli
degener
epitheli
hyperplasia
compar
convent
anim
interestingli
effect
observ
strain
viru
less
pathogen
strain
ifv
caus
minim
mortal
morbid
convent
mice
use
consist
work
ichinoh
et
al
germfre
antibiotictr
mice
challeng
ifv
impair
adapt
immun
respons
shown
lower
influenzaspecif
antibodi
serum
igm
igg
fewer
number
ifvspecif
cell
present
lung
well
reduc
capac
specif
cell
produc
effector
cytokin
moreov
author
demonstr
alter
adapt
immun
respons
relat
defect
earli
innat
immun
respons
mediat
macrophag
fact
transcript
profil
comput
analys
macrophag
antibiotictr
mice
indic
reduc
express
antivir
gene
includ
ifnb
tnfa
compar
immunobiot
influenza
viru
infect
frontier
immunolog
wwwfrontiersinorg
decemb
volum
articl
convent
mice
addit
function
assay
macrophag
antibiotictr
mice
demonstr
cell
defect
respons
type
ifn
impair
capac
limit
ifv
replic
cellular
molecular
mechan
gut
microbiom
deriv
signal
maintain
modul
immun
respons
distal
mucos
site
poorli
understood
two
possibl
mechan
mutual
exclus
propos
explain
benefici
effect
gut
microbiom
one
possibl
distal
mucos
peripher
immun
cell
directli
expos
bacteri
product
activ
prr
steadi
state
help
maintain
normal
immun
tone
evid
bacteri
product
gut
commens
peptidoglycan
absorb
circul
throughout
host
help
modul
normal
develop
immun
cell
line
hypothesi
iwasaki
colleagu
specul
bacteri
product
gut
commens
trigger
prr
stimul
immun
cell
system
factor
releas
cell
support
steadyst
product
nlr
protein
idea
sustain
observ
intestin
inject
tlr
ligand
restor
immun
respons
ifv
antibiotictr
mice
anoth
possibl
commens
bacteria
may
indirectli
influenc
system
distal
mucos
immun
respons
immun
factor
releas
intestin
mucosa
includ
cytokin
chemokin
grow
factor
research
work
demonstr
gut
microbiom
provid
signal
sustain
antivir
innat
immun
defens
mechan
respiratori
tract
allow
robust
effici
effector
respons
upon
challeng
viral
pathogen
ifv
therefor
role
gut
microbiom
regul
respiratori
antivir
immun
repres
excit
area
research
could
help
provid
scientif
basi
develop
novel
prevent
strategi
lung
infecti
diseas
howev
sever
question
need
answer
identifi
new
altern
improv
antivir
respiratori
defens
modul
microbiota
differ
microbi
speci
gut
microbiota
influenc
common
mucos
immun
system
prr
activ
gut
microbiota
function
modul
antivir
immun
local
distal
mucos
site
cellular
function
modul
microbiota
prr
activ
microbiota
abil
influenc
immun
respons
respiratori
virus
similar
immun
mechan
activ
microbiota
highrisk
popul
infant
elderli
immunocompromis
host
respiratori
viral
infect
frequent
sever
possibl
benefici
modul
antivir
respiratori
defens
oral
administ
select
microorgan
immunomodulatori
capac
research
last
year
provid
answer
last
question
first
studi
assess
capac
immunobiot
favor
modul
immun
respons
ifv
focus
humor
immun
tabl
yasui
et
al
report
oral
administr
bifidobacterium
breve
improv
product
antiifv
igg
antibodi
serum
ifvinfect
mice
strain
reduc
viral
titer
improv
surviv
rate
decreas
sever
symptom
associ
influenza
infect
similarli
shown
oral
administ
nonviabl
lactobacillu
pentosu
viabl
lactobacillu
brevi
abl
improv
level
respiratori
specif
iga
igg
antibodi
mice
challeng
ifv
moreov
improv
humor
respons
induc
strain
correl
signific
reduct
viral
titer
bodi
weight
loss
decreas
alter
physic
condit
induc
ifv
recent
kikuchi
et
al
demonstr
benefici
effect
outcom
ifv
infect
relat
improv
respiratori
humor
respons
lactobacillu
plantarum
ayatr
mice
addit
work
propos
mechan
distal
immunomodulatori
activ
induc
oral
administ
immunobiot
author
show
l
plantarum
aya
fed
mice
impact
peyer
patch
pp
induc
activ
antigen
present
cell
mainli
dc
increas
product
chang
promot
igmtoiga
class
switch
recombin
differenti
iga
b
cell
plasma
cell
improv
product
mucos
iga
intestin
respiratori
tract
studi
show
immunobiot
capabl
modul
product
system
mucos
antibodi
influenza
therefor
enhanc
humor
immun
respons
figur
howev
precis
mechan
oral
administ
immunobiot
induc
iga
product
distant
mucos
site
remain
unclear
also
demonstr
immunobiot
abl
improv
cellular
immun
respons
ifv
figur
regard
report
oral
administ
lactobacillu
casei
shirota
improv
outcom
ifv
infect
age
infant
mice
increas
system
respiratori
nk
cell
activ
improv
product
respiratori
lymphocyt
studi
also
demonstr
ifv
titer
significantli
reduc
age
infant
mice
treat
shirota
strain
similar
mechan
propos
explain
improv
humor
respons
postul
immunobiot
l
casei
shirota
stimul
cell
nk
cell
pp
induc
mobil
cell
lung
respiratoryassoci
lymphoid
tissu
produc
enhanc
antivir
defens
sever
studi
corrobor
find
show
similar
effect
oral
administ
lactobacilli
immunobiot
lactobacillu
strain
l
gasseri
l
rhamnosu
gg
l
plantarum
benefici
modul
nk
cell
activ
respons
ifv
diminish
viru
titer
reduc
lung
patholog
chang
tabl
recent
kawahara
et
al
describ
improv
respiratori
antivir
respons
oral
administ
bifidobacteria
strain
shown
bifidobacterium
longum
increas
respiratori
nk
cell
activ
product
result
improv
clinic
symptom
reduc
mortal
decreas
viru
titer
ifv
challeng
research
work
also
demonstr
nasal
administr
immunobiot
interest
altern
improv
cellular
respons
influenza
infect
tabl
hori
et
al
observ
balbc
mice
nasal
treat
nonviabl
l
casei
shirota
increas
level
mediastin
lymphoid
node
lung
improv
cellular
respiratori
immun
correl
benefici
clinic
outcom
ifv
challeng
similar
observ
perform
nasal
administ
l
pentosu
l
rhamnosu
gg
recent
studi
also
demonstr
abil
immunobiot
improv
respiratori
innat
antivir
defens
respiratori
tract
tabl
figur
report
oral
administ
nonviabl
l
plantarum
improv
protect
ifv
increas
type
ifn
product
work
clearli
demonstr
increas
product
induc
immunobiot
strain
correl
reduct
viral
load
lung
well
improv
surviv
infect
mice
recent
shown
l
gasseri
enhanc
surviv
rate
reduc
lung
viral
titer
mice
infect
ifv
interestingli
author
observ
lung
express
antivir
gene
enhanc
l
gasseri
mice
inflammatori
respons
trigger
ifv
differenti
regul
induc
lower
inflammatori
damag
group
also
report
benefici
regul
ifvtrigg
inflammatori
respons
immunobiot
lung
damag
induc
ifv
known
produc
viru
replic
well
uncontrol
inflammatori
respons
character
hypersecret
proinflammatori
cytokin
especi
adequ
product
inflammatori
factor
necessari
protect
ifv
infect
togeth
appropri
regul
antiinflammatori
cytokin
prevent
damag
lung
tissu
thu
proper
balanc
cytokin
key
factor
determin
outcom
ifv
infect
regard
observ
oral
nasal
administ
immunobiot
l
rhamnosu
differenti
regul
level
kinet
inflammatori
cell
cytokin
mice
ifv
challeng
experiment
model
observ
increas
level
respiratori
neutrophil
macrophag
mice
earli
challeng
ifv
later
proinflammatori
cytokin
infiltr
cell
start
decreas
immunobiotictr
anim
contrast
control
mice
paramet
continu
increas
trend
toward
lower
inflammatori
factor
cell
regist
later
ifv
infect
l
rhamnosu
mice
correl
reduc
sever
pulmonari
damag
compar
control
mice
chen
et
al
also
investig
abil
oral
administ
enterococcu
faecali
benefici
modul
innat
immun
respons
influenza
infect
author
observ
strain
protect
mice
ifv
observ
reduc
mortal
weight
loss
lung
viral
titer
expect
ifv
enhanc
level
proinflammatori
mediat
respiratori
tract
includ
treatment
e
clear
immunobiot
initi
crosstalk
immun
system
order
modul
respiratori
antivir
immun
known
exactli
prr
activ
immunobiot
intestin
respiratori
mucosa
function
modul
antivir
immun
local
distal
mucos
site
respect
neither
determin
exactitud
cellular
function
modul
immunobiot
immedi
prr
activ
research
last
decad
demonstr
immunomodulatori
effect
probiot
bacteria
consequ
complex
interact
sever
bacteri
molecul
host
receptor
locat
differ
immun
nonimmun
cell
also
shown
immunomodulatori
properti
immunobiot
depend
strain
therefor
studi
carri
certain
strain
easili
extrapol
bacteria
even
genu
speci
consequ
still
necessari
carri
deeper
studi
find
molecular
mechan
immunobiot
benefici
influenc
respiratori
antivir
immun
studi
mention
show
potenti
immunobiot
use
reduct
incid
sever
ifv
infect
howev
addit
deepen
knowledg
mechan
action
sever
point
consid
effici
applic
immunobiot
human
exampl
necessari
determin
best
time
well
appropri
rout
administr
immunobiot
use
compon
function
food
includ
diet
regular
basi
thu
help
improv
respiratori
defens
especi
highrisk
popul
season
highest
incid
respiratori
infect
occur
sens
random
control
trial
demonstr
l
rhamnosu
administ
yogurt
formul
improv
mucos
immun
reduc
incid
sever
intestin
respiratori
infect
children
henc
incid
infecti
event
reduc
placebo
group
group
receiv
probiot
yogurt
furthermor
also
signific
reduct
occurr
indic
diseas
sever
fever
need
antibiot
treatment
children
receiv
probiot
yogurt
immunobiot
yogurt
yogurito
includ
offici
nation
nutrit
program
argentina
given
daili
children
school
sever
provinc
thank
govern
action
epidemiolog
studi
school
receiv
immunobiot
product
shown
reduct
incid
infect
associ
school
absente
alvarez
et
al
unpublish
result
hand
mention
earlier
nasal
administr
immunobiot
effici
oral
administr
enhanc
respiratori
immun
rout
administr
pose
practic
disadvantag
consid
treatment
immunobiot
show
favor
result
use
infecti
challeng
way
would
necessari
predict
exact
moment
viral
pathogen
contact
host
order
carri
prophylact
immunobiot
treatment
option
could
use
exampl
school
work
outbreak
case
respiratori
infect
occur
desir
prevent
reduc
sever
infect
asymptomat
individu
intervent
characterist
would
also
import
determin
exact
time
contact
viru
possibl
administ
immunobiot
achiev
benefici
effect
recent
studi
percopo
et
al
defin
window
opportun
work
evalu
effect
nasal
administr
live
inactiv
l
plantarum
ncimb
mice
model
sever
respiratori
infect
pneumonia
viru
mice
pvm
found
immunobiot
treatment
promot
full
surviv
acut
pvm
infect
administ
within
day
viru
challeng
similar
studi
would
valu
ifv
infect
model
anoth
point
interest
relat
durat
improv
respiratori
defens
last
immunobiot
administr
studi
show
immunomodulatori
effect
nasal
administ
immunobiot
persist
least
day
villena
et
al
unpublish
result
studi
also
report
shortterm
protect
nasal
treatment
differ
immunobiot
strain
interestingli
garciacrespo
et
al
found
adult
mice
prime
nasal
l
plantarum
ncimb
lactobacillu
reuteri
complet
protect
lethal
pvm
infect
protect
persist
least
month
initi
prime
find
open
interest
challeng
studi
immunobiot
improv
defens
ifv
sinc
would
use
establish
durat
protect
effect
strain
treatment
sinc
major
case
longterm
studi
taken
account
ifv
infect
often
result
mild
moder
lung
infect
howev
lifethreaten
diseas
occur
demonstr
sever
diseas
outcom
associ
secondari
bacteri
pneumonia
caus
primarili
staphylococcu
aureu
streptococcu
pneumonia
take
account
high
incid
viral
infect
frequenc
associ
secondari
bacteri
infect
contribut
aggrav
health
statu
host
reduc
chanc
recoveri
variou
approach
prevent
treat
influenza
secondari
bacteri
pneumonia
investig
wide
rang
antibiot
antiinflammatori
drug
test
mice
review
ref
would
interest
evalu
potenti
benefici
effect
immunobiot
circumst
regard
preliminari
studi
laboratori
show
nasal
administ
l
rhamnosu
abl
improv
surviv
reduc
bacteri
cell
count
lung
blood
limit
lung
inflammatori
damag
caus
pneumonia
infect
mice
produc
infect
ifv
respiratori
syncyti
viru
rsv
villena
et
al
unpublish
result
result
open
interest
topic
futur
investig
final
would
also
interest
investig
whether
immunobiot
treatment
may
influenc
physiolog
system
involv
defens
viral
respiratori
infect
coagul
system
group
made
progress
regard
mention
coagul
extrem
order
process
involv
interact
three
key
compon
endotheli
cell
ec
platelet
coagul
factor
tissu
injuri
activ
ec
typic
initi
coagul
character
bind
platelet
activ
ec
format
platelet
plug
almost
simultan
tissu
factor
tf
releas
ec
result
factor
x
activ
induc
thrombin
gener
fibrin
strand
strengthen
platelet
plug
lead
stabl
plateletfibrin
clot
process
tightli
regul
anticoagul
fibrinolyt
mechan
avoid
thrombot
andor
haemorrhag
complic
key
role
attribut
ec
tempor
special
regul
coagul
activ
rest
ec
avoid
inappropri
plug
format
control
platelet
adhes
activ
gener
sever
anticoagul
factor
provid
nonthrombogen
barrier
activ
injur
ec
expos
collagen
blood
increas
platelet
bind
aggreg
reduc
express
physiolog
anticoagul
factor
increas
express
tf
von
willebrand
factor
suppress
fibrinolyt
activ
chang
hemostat
system
facilit
thrombosi
infect
inflamm
tissu
hemorrhag
thrombot
complic
describ
ifv
infect
influenza
abl
caus
pulmonari
hemorrhag
edema
relat
coagulopathi
induc
uncontrol
thrombosi
overactiv
coagul
figur
anim
model
help
explain
mechan
ifv
infect
activ
coagul
key
role
attribut
tf
describ
ifv
activ
coagul
enhanc
tf
product
thrombin
gener
fibrin
deposit
mice
mice
model
ifv
infect
recent
shown
wildtyp
anim
increas
lung
tf
express
activ
coagul
present
alveolar
hemorrhag
moreov
select
delet
tf
epitheli
cell
lung
significantli
reduc
tf
express
ifv
infect
higher
alveolar
hemorrhag
immunobiot
influenza
viru
infect
frontier
immunolog
wwwfrontiersinorg
decemb
volum
articl
reduc
surviv
control
contrari
defici
tf
either
respiratori
myeloid
cell
ec
enhanc
alveolar
hemorrhag
modifi
surviv
ifvinfect
mice
result
indic
appropri
modul
product
tf
lung
ifv
infect
necessari
maintain
tissu
hemostasi
avoid
hemorrhag
excess
fibrin
deposit
product
tf
lung
epitheli
cell
requir
maintain
alveolar
hemostasi
ifv
infect
excess
releas
tf
macrophag
ec
would
contribut
patholog
lung
tissu
injuri
consid
ec
may
play
import
role
pathogenesi
ifv
influenza
infect
abl
induc
alveolar
edema
pulmonari
hemorrhag
alter
ec
via
sever
mechan
includ
direct
damag
loss
tight
junction
apoptosi
addit
recognit
damageassoci
molecular
pattern
oxid
phospholipid
activ
ec
drive
lung
injuri
direct
stimul
viral
rna
also
result
upregul
tf
downregul
thrombomodulin
tm
ec
time
inflammatori
activ
ec
lead
activ
coagul
cascad
inflamm
caus
ifv
infect
increas
variou
proinflammatori
cytokin
induc
secret
tf
ec
monocyt
addit
role
coagul
activ
protein
thrombin
fxa
fviia
also
enhanc
inflammatori
respons
inflammatori
potenti
abil
coagul
factor
mediat
activ
proteaseactiv
receptor
par
express
platelet
ec
macrophag
respiratori
epitheli
cell
pathway
associ
promot
deleteri
innat
inflammatori
respons
ifv
infect
mice
therefor
hyperinflammatori
respons
aberr
activ
coagul
potenti
involv
sever
influenza
pneumonia
key
event
control
order
reach
favor
resolut
infecti
process
consid
import
coagul
respons
outcom
influenza
infect
abil
immunobiot
benefici
influenc
immun
respons
respiratori
pathogen
wonder
whether
immunobiot
strain
would
abl
benefici
modul
immunocoagul
respons
trigger
ifv
purpos
perform
challengeinfect
experi
mice
evalu
influenc
viabl
nonviabl
immunobiot
l
rhamnosu
strain
respiratori
immunocoagul
respons
induc
ifv
data
demonstr
oral
administr
l
rham
nosu
mice
significantli
reduc
lung
viral
titer
tissu
damag
challeng
ifv
later
explor
capac
nasal
administ
l
rhamnosu
aliv
heat
kill
reduc
influenza
burden
diseas
treatment
induc
signific
decreas
ifv
titer
lung
lessen
pulmonari
damag
increas
surviv
interestingli
similar
effect
achiev
nasal
administr
viabl
nonviabl
strain
moreov
nasal
rout
effici
oral
administr
protect
mice
ifv
infect
protect
effect
achiev
immunobiot
strain
relat
abil
modul
respiratori
antivir
immun
respons
particularli
capac
improv
level
respiratori
tract
figur
type
ifn
trigger
activ
jakstat
pathway
increas
express
antivir
gene
addit
produc
immun
cell
especi
cell
improv
antivir
immun
respons
induc
activ
nk
cell
macrophag
therefor
modul
type
ifn
would
respons
reduct
viral
load
ifvinfect
mice
previous
treat
strain
similarli
immunobiot
strain
mention
tabl
demonstr
strain
increas
level
gut
cell
induc
mobil
lymphocyt
lung
enhanc
respiratori
product
activ
local
antigen
present
cell
also
note
nasal
administr
effect
oral
rout
increas
pulmonari
cell
mechan
nasal
administ
viabl
heatkil
l
rhamnosu
improv
cell
popul
clear
howev
studi
support
possibl
immunobiot
strain
l
rhamnosu
impact
nasalassoci
lymphoid
tissu
bronchialassoci
lymphoid
tissu
produc
innat
imprint
antigen
present
cell
contribut
enhanc
number
activ
cell
studi
also
show
immunobiot
treatment
abl
benefici
modul
activ
coagul
respiratori
viral
infect
effect
report
studi
first
demonstr
benefici
modul
immunecoagul
respons
respiratori
activ
ifv
infect
induc
immunobiot
microorgan
figur
although
ifv
ssrna
viru
gener
dsrna
replic
intermedi
activ
contribut
initi
antivir
respiratori
immun
respons
fact
ifv
trigger
type
ifn
secret
recognit
immun
myeloid
dc
macrophag
nonimmun
fibroblast
pneumocyt
cell
challengeinfect
experi
respiratori
virus
mice
show
modifi
clearanc
viral
pathogen
relev
modul
lung
inflammatori
respons
show
wildtyp
mice
mount
robust
inflammatori
respons
lung
ifv
infect
process
significantli
diminish
anim
mice
show
longer
surviv
compar
wildtyp
anim
effect
associ
reduct
inflammatori
cell
recruit
lower
level
inflammatori
factor
respiratori
tract
vivo
studi
also
demonstr
activ
poli
c
enhanc
proinflammatori
cytokin
immunobiot
influenza
viru
infect
frontier
immunolog
wwwfrontiersinorg
decemb
volum
articl
antivir
factor
express
alter
vascular
permeabl
increment
level
ddimer
indic
coagul
fibrinolysi
trigger
line
find
observ
level
ddimer
mice
significantli
lower
wildtyp
anim
poli
c
administr
neutrophil
macrophag
proinflammatori
mediat
respiratori
tract
moreov
activ
also
induc
increas
tf
express
thrombinantithrombin
complex
tatc
level
lung
reduc
tm
express
inflammatorycoagul
modif
accompani
respiratori
tissu
alter
impair
lung
function
interest
demonstr
oral
nasal
administ
immunobiot
challeng
poli
c
differenti
modul
inflammatorycoagul
respons
l
rhamnosu
abl
reduc
increas
express
tf
tm
respect
respiratori
activ
thu
strain
significantli
diminish
coagul
activ
blood
respiratori
tract
nasal
stimul
poli
c
also
evalu
pulmonari
coagul
ifv
infect
respiratori
viru
induc
activ
coagul
lung
infect
mice
demonstr
increas
level
respiratori
tatc
procoagul
chang
relat
alter
express
tm
tf
lung
find
line
previou
studi
human
anim
model
influenza
infect
demonstr
increas
lung
fibrin
deposit
enhanc
number
intravascular
thrombi
respiratori
tract
demonstr
immunobiot
treatment
abl
significantli
diminish
activ
coagul
ifvchalleng
mice
fact
lower
level
respiratori
tatc
reduc
express
tf
observ
l
rhamnosu
mice
infect
ifv
compar
control
mention
ifv
promot
procoagul
state
directli
capac
infect
ec
monocyt
stimul
express
tf
addit
ifv
induc
activ
coagul
indirectli
enhanc
proinflammatori
factor
therefor
abil
immunobiot
modul
ifvtrigg
immunecoagul
respons
could
explain
direct
influenc
viral
replic
relat
enhanc
antivir
state
respiratori
mucosa
indirectli
modul
inflammatori
respons
consid
last
point
perform
experi
use
block
antibodi
order
evalu
role
regul
inflammatori
respons
reduct
coagul
activ
result
show
import
regul
coagul
induc
immunobiot
l
rhamnosu
block
abolish
capac
strain
chang
express
tm
tf
lung
line
previou
studi
evalu
abil
l
rhamnosu
confer
protect
inflammatori
damag
induc
activ
rsv
infect
show
key
factor
reduct
lung
injuri
addit
demonstr
lethal
diseas
caus
ifv
infect
prevent
administr
reduct
lung
immunopatholog
moreov
tf
express
procoagul
activ
macrophag
ec
reduc
therefor
demonstr
immunobiot
administr
induc
earli
increas
level
tnf
respiratori
tract
poli
c
rsv
ifv
challeng
level
proinflammatori
factor
significantli
reduc
later
infect
earli
increas
proinflammatori
mediat
augment
level
explain
abil
l
rhamnosu
diminish
viral
replic
improv
product
would
lead
benefici
modul
immunecoagul
respons
result
reduc
sever
lung
damag
suggest
respiratori
viral
infect
increas
risk
venou
thromboembol
ischem
heart
diseas
ec
perturb
coagul
activ
reduct
anticoagul
factor
inhibit
fibrinolysi
studi
suggest
immunobiot
could
interest
altern
reduc
incid
andor
sever
respiratori
viral
infect
addit
reduc
risk
atherothrombot
alter
associ
respiratori
viral
infect
research
last
decad
clearli
demonstr
benefici
microorgan
abl
modul
respiratori
tract
immun
promot
resolut
lessen
sever
respiratori
infect
caus
pathogen
ifv
studi
anim
model
demonstr
oral
nasal
administ
immunobiot
abl
improv
protect
ifv
three
main
mechan
first
immunobiot
increas
respiratori
antivir
state
capac
improv
level
type
ifn
number
activ
antigen
present
cell
nk
cell
iga
b
lymphocyt
well
level
system
mucos
specif
antibodi
second
immunobiot
benefici
modul
ifvtrigg
respiratori
inflammatori
respons
induc
chang
level
kinet
proinflammatori
factor
immunoregulatori
cytokin
allow
clearanc
viru
minim
inflammatori
lung
tissu
damag
final
demonstr
recent
research
work
immunobiot
modul
lung
immunecoagul
respons
trigger
activ
ifv
infect
mainli
downregul
lung
tf
restor
tm
level
studi
anim
model
suggest
immunobiot
would
influenc
princip
innat
immun
respons
modul
way
earli
antivir
inflammatori
respons
subsequ
cellular
humor
immun
respons
therefor
immunobiot
would
mainli
adjuv
effect
howev
exact
molecular
mechan
immunobiot
differenti
modul
innat
antivir
immun
respons
ifv
remain
elucid
addit
grow
number
studi
human
examin
effect
immunobiot
incid
sever
ifv
infect
consid
impact
immunobiot
innat
immun
respons
clinic
studi
evalu
princip
potenti
adjuv
effect
ifv
vaccin
tabl
although
mechanist
studi
address
depth
promis
evid
benefici
effect
immunobiot
human
respiratori
health
resist
ifv
observ
might
help
propos
new
